PatientsVille.com Logo

PatientsVille

Madopar Side Effects

Common Madopar Side Effects


The most commonly reported Madopar side effects (click to view or check a box to report):

Diarrhoea (6)
Pneumonia (5)
Haematemesis (4)
Tremor (4)
Gastrointestinal Haemorrhage (4)
Atrial Fibrillation (3)
Completed Suicide (3)
Fatigue (3)
Somnolence (3)
Blood Pressure Increased (2)
Blood Lactate Dehydrogenase Increased (2)
Muscle Spasms (2)
Cardiac Failure (2)
Myocardial Infarction (2)
Off Label Use (2)
Orthostatic Hypotension (2)
Parkinson's Disease (2)
Parkinsonism (2)
Pathological Gambling (2)
Pleural Effusion (2)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Madopar Side Effects Reported to FDA

The following Madopar reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Madopar on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Retinal Haemorrhage
This is a report of a female patient (weight: NA) from SPAIN, suffering from the following symptoms/conditions: parkinson's disease,prophylaxis against gastrointestinal ulcer,hypertension,atrial fibrillation, who was treated with Madopar (dosage: 200 / 50 Mg, start time: Apr 11, 2012), combined with:
  • Omeprazole (20 Mg)
  • Openvas Plus (20 / 25 Mg)
  • Pradaxa (220 Mg)
  • Atenolol (100 Mg)
  • Metformin Hcl (1700 Mg)
  • Mastical D (1000 Mg)
  • Sinvastatina (40 Mg)
  • Somnovit (1 Mg)
and developed a serious reaction and side effect(s). The consumer presented with:
  • Retinal Haemorrhage
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Madopar treatment in female patients, resulting in retinal haemorrhage side effect.

Erythema, Alopecia, Urticaria, Tremor, Pruritus, Skin Burning Sensation, Hypertransaminasaemia, Product Adhesion Issue
This report suggests a potential Madopar Erythema, Alopecia, Urticaria, Tremor, Pruritus, Skin Burning Sensation, Hypertransaminasaemia, Product Adhesion Issue side effect(s) that can have serious consequences. A 76-year-old female patient (weight: NA) from GERMANY was diagnosed with the following symptoms/conditions: NA and used Madopar (dosage: NA) starting Mar 10, 2012. Soon after starting Madopar the patient began experiencing various side effects, including:
  • Erythema
  • Alopecia
  • Urticaria
  • Tremor
  • Pruritus
  • Skin Burning Sensation
  • Hypertransaminasaemia
  • Product Adhesion Issue
Drugs used concurrently:
  • Novalgin (At 07:00am, 11:00a, 03:00pm, 06:00pm)
  • Madopar Lt (At 06:00 Am)
  • Estradiol (On Wednesday And Saturday)
  • Neupro
  • Neupro
  • Torsemide (At 06:00am)
  • Pantoprazole (At 07:00am)
  • Diovan (160 Mg At 07:00am And 80 Mg At 06:00pm)
Although Madopar demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as erythema, may still occur.

Pyrexia, Inflammation, Stupor, Dysarthria, Somnolence, Pleural Effusion, Blood Pressure Increased
This Pyrexia, Inflammation, Stupor, Dysarthria, Somnolence, Pleural Effusion, Blood Pressure Increased problem was reported by a consumer or non-health professional from HUNGARY. A 62-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On Mar 03, 2012 this consumer started treatment with Madopar (dosage: NA). The following drugs were being taken at the same time:
  • Olanzapine (300 Mg, Monthly (1/m))
When commencing Madopar, the patient experienced the following unwanted symptoms/side effects:
  • Pyrexia
  • Inflammation
  • Stupor
  • Dysarthria
  • Somnolence
  • Pleural Effusion
  • Blood Pressure Increased
The patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as pyrexia, may become evident only after a product is in use by the general population.

Cardiac Failure
This is a report of a 81-year-old female patient (weight: NA) from GERMANY. The patient developed the following symptoms/conditions: NA and was treated with Madopar (dosage: NA) starting Mar 29, 2012. Concurrently used drugs:
  • Memantine Hcl (5 Mg)
Soon after that, the consumer experienced the following side effects:
  • Cardiac Failure
This opens a possibility that Madopar treatment could cause the above reactions, including cardiac failure, and some female subjects may be more susceptible.


Anaemia
A 56-year-old female patient (weight: NA) from GERMANY with the following symptoms/conditions: NA started Madopar treatment (dosage: NA) on Aug 08, 2011. Soon after starting Madopar treatment, the subject experienced various side effects, including:
  • Anaemia
Concurrently used drugs:
  • Sulpirid
  • Aspirin
  • Tysabri
  • Methizol 5
The patient was hospitalized. This finding indicates that some female patients could be more vulnerable to Madopar.

Renal Tubular Disorder, Thrombotic Microangiopathy
A 35-year-old female patient from SWITZERLAND (weight: NA) experienced symptoms, such as: NA and was treated with Madopar(dosage: NA). The treatment was initiated on Nov 01, 2011. After that a consumer reported the following side effect(s):
  • Renal Tubular Disorder
  • Thrombotic Microangiopathy
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Madopar efficacy:
  • Cellcept
  • Bactrim
  • Diflucan
  • Prograf
  • Prograf
  • Pantoprazole
The patient was hospitalized.

Myocardial Infarction, Pneumonia, Atrial Fibrillation, Off Label Use
In this report, Madopar was administered for the following condition: parkinson's disease.A 74-year-old male consumer from UNITED KINGDOM (weight: NA) started Madopar treatment (dosage: 125mg Per Day) on Feb 12, 2012.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Myocardial Infarction
  • Pneumonia
  • Atrial Fibrillation
  • Off Label Use
A possible interaction with other drugs could have contributed to this reaction:
  • Apomorphine Hydrochloride
  • Stalevo 100 (1200mg Per Day)
  • Domperidone (60mg Per Day)
  • Requip Xl (20mg Per Day)
The patient was hospitalized.Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Madopar treatment could be related to the listed above side effect(s).

Atrial Fibrillation, Off Label Use, Myocardial Infarction, Pneumonia
This is a report of the following Madopar side effect(s):
  • Atrial Fibrillation
  • Off Label Use
  • Myocardial Infarction
  • Pneumonia
A 74-year-old male patient from UNITED KINGDOM (weight: NA) presented with the following condition: parkinson's disease and received a treatment with Madopar (dosage: 125mg Per Day) starting: Feb 12, 2012.The following concurrently used drugs could have generated interactions:
  • Stalevo 100 (1200mg Per Day)
  • Apomorphine Hydrochloride
  • Requip Xl (20mg Per Day)
  • Domperidone (60mg Per Day)
The patient was hospitalized.This report suggests that a Madopar treatment could be associated with the listed above side effect(s).

Sudden Onset Of Sleep
This Madopar report was submitted by a 63-year-old male consumer from JAPAN (weight: NA). The patient was diagnosed with: parkinson's disease and Madopar was administered (dosage: NA) starting: Feb 01, 2012. The consumer developed a set of symptoms:
  • Sudden Onset Of Sleep
Other drugs used simultaneously:
  • Artane
  • Comtan
  • Pramipexole Dihydrochloride (1.125 Mg)
Those unexpected symptoms could be linked to a Madopar treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

Orthostatic Hypotension
This is a report of a possible correlation between Madopark use and the following symptoms/side effect(s):
  • Orthostatic Hypotension
which could contribute to an assessment of Madopark risk profile.A 91-year-old female consumer from SWEDEN (weight: NA) was suffering from NA and was treated with Madopark (dosage: NA) starting NS.Other concurrent medications:
  • Aspirin
  • Atenolol
  • Oralvite
  • Kalcipos
  • Alendronate Sodium
  • Felodipine
  • Prednisolone
  • Omeprazole
The patient was hospitalized.

Cardiac Failure, Atrial Fibrillation, Pleural Effusion, Congestive Cardiomyopathy
A 75-year-old male patient from GERMANY (weight: NA) presented with the following symptoms: parkinson's disease and after a treatment with Madopar (dosage: NA) experienced the following side effect(s):
  • Cardiac Failure
  • Atrial Fibrillation
  • Pleural Effusion
  • Congestive Cardiomyopathy
The treatment was started on Oct 07, 2010. Madopar was used in combination with the following drugs:
  • Clarium
  • Tasmar
  • L-dopa-retard
  • L-dopa
  • Azilect
The patient was hospitalized and became disabled.This report could alert potential Madopar consumers.

Tremor, Musculoskeletal Stiffness, Paralysis
In this report, a 71-year-old male patient from GERMANY (weight: NA) was affected by a possible Madopar side effect.The patient was diagnosed with NA. After a treatment with Madopar (dosage: NA, start date: Mar 01, 2012), the patient experienced the following side effect(s):
  • Tremor
  • Musculoskeletal Stiffness
  • Paralysis
The following simultaneously used drugs could have led to this reaction:
  • Neupro
The findings here stress that side effects should be taken into consideration when evaluating a Madopar treatment.

Haematemesis, Gastrointestinal Haemorrhage
This is a report of a male patient from GERMANY (weight: NA), who used Madopar Lt (dosage: 4 Anz) for a treatment of parkinson's disease. After starting a treatment on Jan 26, 2012, the patient experienced the following side effect(s):
  • Haematemesis
  • Gastrointestinal Haemorrhage
The following drugs could possibly have interacted with the Madopar Lt treatment
  • Bisoprolol Fumarate (2.5 Mg)
  • Allopurinol (300 Mg)
  • Pradaxa (220 Mg)
  • Madopar Dep
  • Captohexal (12.5 Mg)
  • Madopar Dep (1000 Mg)
  • Xipamid (40 Mg)
  • Rimantadin (300 Mg)
Taken together, these observations suggest that a Madopar Lt treatment could be related to side effect(s), such as Haematemesis, Gastrointestinal Haemorrhage.

Gait Disturbance
This gait disturbance side effect was reported by a physician from GERMANY. A 71-year-old female patient (weight:NA) experienced the following symptoms/conditions: parkinson's disease. The patient was prescribed Madopar (dosage: NA), which was started on Apr 15, 2010. Concurrently used drugs:
  • Madopar Lt
When starting to take Madopar the consumer reported the following symptoms:
  • Gait Disturbance
The patient was hospitalized. These side effects may potentially be related to Madopar.

Communication Disorder, Disorientation, Bedridden, Fatigue, Somnolence, Eating Disorder, Malaise
This is a Madopark side effect report of a 70-year-old male patient (weight:NA) from SWEDEN, suffering from the following symptoms/conditions: NA, who was treated with Madopark (dosage:100mg/25mg, start time: NS), combined with:
  • Madopark - Slow Release (Unk)
  • Lactulose (Unk)
  • Orstanorm (5 Mg, Unk)
  • Mirtazapine (Unk)
  • Bicalutamide (Unk)
  • Clonazepam (0.5 Mg, Unk)
  • Toviaz (Unk)
  • Aspirin (75 Mg, Unk)
, and developed a serious reaction and a communication disorder side effect. The patient presented with:
  • Communication Disorder
  • Disorientation
  • Bedridden
  • Fatigue
  • Somnolence
  • Eating Disorder
  • Malaise
which developed after the beginning of treatment. The patient was hospitalized. This side effect report can indicate a possible existence of increased vulnerability to Madopark treatment in male patients suffering from NA, resulting in communication disorder.

Dystonia
This report suggests a potential Madopar dystonia side effect(s) that can have serious consequences. A female patient from JAPAN (weight:NA) was diagnosed with the following health condition(s): parkinson's disease,constipation and used Madopar (dosage: NA) starting Nov 01, 2011. Soon after starting Madopar the patient began experiencing various side effects, including:
  • Dystonia
Drugs used concurrently:
  • Gasmotin
  • Permax
  • Donepezil Hcl
  • Magmitt
  • Vesicare Od
  • Donepezil Hcl
The patient was hospitalized. Although Madopar demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as dystonia, may still occur.

Gastrointestinal Haemorrhage, Haematemesis
This gastrointestinal haemorrhage problem was reported by a physician from GERMANY. A male patient (weight: NA) was diagnosed with the following medical condition(s): parkinson's disease.On Jan 26, 2012 a consumer started treatment with Madopar Lt (dosage: 2 Anz). The following drugs/medications were being taken at the same time:
  • Madopar Dep (4 Anz)
  • Pradaxa (220 Mg)
  • Glimepirid (1 Mg)
When commencing Madopar Lt, the patient experienced the following unwanted symptoms /side effects:
  • Gastrointestinal Haemorrhage
  • Haematemesis
Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as gastrointestinal haemorrhage, may become evident only after a product is in use by the general population.

Cerebrovascular Accident, Pulmonary Embolism
This is a Madopark side effect report of a 67-year-old male patient (weight: NA) from SWEDEN. The patient developed the following symptoms/conditions: NA and was treated with Madopark (dosage: 1 Df, Tid) starting Jun 01, 2010. Concurrently used drugs:
  • Ondansetron (4 Mg, Prn)
  • Mollipect (Unk Unk, Prn)
  • Miniderm /00021201/ (1 Unk, Bid)
  • Novaluzid (Unk Unk, Prn)
  • Laktulos (Unk Unk, Prn)
  • Vectibix (6 Mg/kg, Q2wk)
  • Rozex /00012501/ (Unk)
  • Primperan Tab (10 Mg, Prn)
Soon after that, the consumer experienced the following of symptoms:
  • Cerebrovascular Accident
  • Pulmonary Embolism
The patient was hospitalized. This opens a possibility that Madopark could cause cerebrovascular accident and that some male patients may be more susceptible.

Gastrointestinal Haemorrhage, Haematemesis
A male patient (weight: NA) from GERMANY with the following symptoms: parkinson's disease,atrial fibrillation started Madopar Dep treatment (dosage: 4 Anz) on Jan 26, 2012. Soon after starting Madopar Dep treatment, the consumer experienced several side effects, including:
  • Gastrointestinal Haemorrhage
  • Haematemesis
. Concurrently used drugs:
  • Pradaxa (220 Mg)
  • Madopar Lt (2 Anz)
  • Glimepirid (1 Mg)
This finding indicates that some patients can be more vulnerable to developing Madopar Dep side effects, such as gastrointestinal haemorrhage.

Cerebral Haemorrhage, Gastrointestinal Haemorrhage, Haematemesis
This cerebral haemorrhage side effect was reported by a physician from GERMANY. A male patient (weight:NA) experienced the following symptoms/conditions: parkinson's disease,type 2 diabetes mellitus,atrial fibrillation.The patient was prescribed Madopar Dep (dosage: 4 Anz), which was started on Jan 26, 2012. Concurrently used drugs:
  • Glimepirid (1 Mg)
  • Pradaxa (220 Mg)
  • Madopar Lt (2 Anz)
.When starting to take Madopar Dep the consumer reported symptoms, such as:
  • Cerebral Haemorrhage
  • Gastrointestinal Haemorrhage
  • Haematemesis
These side effects may potentially be related to Madopar Dep.

Somnolence, Nightmare, Hallucination
This is a report of a 60-year-old female patient (weight: NA) from UNITED KINGDOM, suffering from the following symptoms/conditions: parkinson's disease, who was treated with Madopar (dosage: NA, start time: NS), combined with:
  • Requip Xl (18mg In The Morning)
and developed a serious reaction and side effect(s). The consumer presented with:
  • Somnolence
  • Nightmare
  • Hallucination
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Madopar treatment in female patients, resulting in somnolence side effect.

Parkinson's Disease, Tremor
This report suggests a potential Madopar Parkinson's Disease, Tremor side effect(s) that can have serious consequences. A 66-year-old female patient (weight: NA) from GERMANY was diagnosed with the following symptoms/conditions: NA and used Madopar (dosage: NA) starting Jan 01, 2011. Soon after starting Madopar the patient began experiencing various side effects, including:
  • Parkinson's Disease
  • Tremor
Drugs used concurrently:
  • Sprycel
Although Madopar demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as parkinson's disease, may still occur.

Enterocolitis Bacterial
This Enterocolitis Bacterial problem was reported by a physician from JAPAN. A female patient (weight: NA) was diagnosed with the following symptoms/conditions: parkinson's disease. On Mar 24, 2009 this consumer started treatment with Madopar (dosage: NA). The following drugs were being taken at the same time:
  • Mevarich
  • Clonazepam
  • Magmitt
  • Donepezil Hcl
  • Yakuban (Ac)
  • Proranon
  • Cabergoline
When commencing Madopar, the patient experienced the following unwanted symptoms/side effects:
  • Enterocolitis Bacterial
The patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as enterocolitis bacterial, may become evident only after a product is in use by the general population.

Blood Lactate Dehydrogenase Increased, Fibrin D Dimer Increased, Deep Vein Thrombosis, Pulmonary Artery Thrombosis
This is a report of a 73-year-old male patient (weight: NA) from UNITED STATES. The patient developed the following symptoms/conditions: NA and was treated with Madopar (dosage: NA) starting Aug 26, 2011. Concurrently used drugs:
  • Micardis (40 Mg, Qd)
  • Romiplate (70 Mug, Qwk)
  • Romiplate (Unk Unk, One Time Dose)
  • Prednisolone (12.5 Mg, Qd)
  • Romiplate (70 Mug, Q2wk)
Soon after that, the consumer experienced the following side effects:
  • Blood Lactate Dehydrogenase Increased
  • Fibrin D Dimer Increased
  • Deep Vein Thrombosis
  • Pulmonary Artery Thrombosis
This opens a possibility that Madopar treatment could cause the above reactions, including blood lactate dehydrogenase increased, and some male subjects may be more susceptible.

Diarrhoea, Coeliac Disease
A 73-year-old male patient (weight: NA) from SWITZERLAND with the following symptoms/conditions: NA started Madopar Dr treatment (dosage: NA) on Apr 25, 2009. Soon after starting Madopar Dr treatment, the subject experienced various side effects, including:
  • Diarrhoea
  • Coeliac Disease
Concurrently used drugs: NA.The patient was hospitalized. This finding indicates that some male patients could be more vulnerable to Madopar Dr.

1 of 3 



Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


    Discuss Madopar Side Effects

    Did You Have a Madopar Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Madopar for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective